TARA generates human relevant data to enable faster, safer, and more accurate development of new treatments. Our platform can reduce cost and increase the success of important new medicines reaching patients.

Cardiac Drug Discovery

We generate disease models from stem cells, enabling discovery of new medicines for heart conditions.

Cardiac Safety

Our cardiac tissue models reliably represent adult human hearts when applied to drug testing. We can accurately identify cardiovascular complications.

Precision Cardiology

Our platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment.


TARA Biosystems Launches Cardiotype.Ca™ Cardiac Calcium Signaling Assay: In Vitro Assay Accelerates Drug Development in Human-Relevant Heart Models

​​ TARA Biosystems, Inc. launched Cardiotype.Ca™, its in vitro system for assessing cardiac calcium signaling. The new assay …


Heart-on-a-Chip Mimics Drug Response Seen in Humans: In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery

NEW YORK, N.Y. (— Researchers from TARA Biosystems, Inc. and GlaxoSmithKline (GSK) today published data demonstrating that TARA’s engineered heart-on-a-chip system replicated drug responses found in …


TARA Secures Exclusive Worldwide License to Columbia University Intellectual Property relating to Engineered Human Cardiac Tissues

NEW YORK, N.Y. (— TARA Biosystems, Inc. (TARA), a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced …


Contact Us

Have a question? Want to request a study with TARA? Please fill out and submit the contact form, and we’ll get back to you as soon as we can.